Feedback / Questions
icovamenib (BMF-219) - Biomea Fusion
https://www.globenewswire.com/news-release/2025/11/05/3181272/0/en/Biomea-Fusion-Showcases-Preclinical-Advances-for-BMF-650-and-Icovamenib-with-Low-Dose-Semaglutide-at-ObesityWeek-2025.html
Nov 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next